Detail of "7790-60-5"

MSDS Download
CAS Number:
7790-60-5
Name:
Tungstate (WO42-),potassium (1:2), (T-4)-
Molecular Structure:
Formula:
K₂O₄W
Molecular Weight:
326.03
Synonyms:
Potassiumtungstate(VI) (K2WO4) (6CI,7CI);Tungstate (WO42-), dipotassium, (T-4)- (9CI);Tungstic acid (H2WO4), dipotassium salt (8CI);Dipotassium tetraoxotungstate;Dipotassium tetraoxotungstate(2-);Potassium tungstate (K2WO4);Potassiumtungsten oxide (K2WO4);
EINECS:
232-215-2
Density:
3.12 g/mL at 25 °C(lit.)
Melting Point:
921 °C(lit.)

Display：

Verified-Platinum Supplier 2nd Year Platinum
Supplier

Tel:0086-010-51669969

Address:10 floor,Tian long hua he building, Baiqiang road, South of Kefeng bridge, Fengtai district, Beijing

POTASSIUM TUNGSTATE

Supplier:Lorad Chemical Corporation [ United States]

510 Integral
510

Tel:727-826-5511

Address:1200 19th Street North St. Petersburg FL, 33713

Supplier:Chem-Met Co [ United States]

119 Integral
119

Tel:+1-(301)-868-3355

Address:P.O. Box 819, Clinton, Maryland 20735, U.S.A.

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Crystal growth of erbium(3+) ytterbium(3+) co-doped potassium yttrium tungstate (KY(WO4)2): Crystal growth of erbium(3+) ytterbium(3+) co-doped potassium yttrium tungstate (KY(WO4)2). Wang, Guofu; Luo, Zundu (Fujian Inst. Res. Struct. Matter, Chin. Acad. Sci., Fuzhou 35002, Peop. Rep. China). J. Cryst. Growth, 116(3-4), 505-6 (English) 1992. CODEN: JCRGAE. ISSN: 0022-0248. DOCUMENT TYPE: Journal CA Section: 75 (Crystallography and Liquid Crystals) Section cross-reference(s): 68, 73 The phase diagram of KY(WO4)2-K2WO4 was detd. 20596-83-2 and 7790-60-5 which are cas registry numbers of substances are two of reagents here. by DTA and x-ray diffraction. Large crystals of KY(WO4)2 co-doped with Er3+ and Yb3+ with dimensions of up to 76′66′32 mm were grown from a K2WO4 flux. The absorption spectra were measured. .

Tungsten (VI) compositions for the oral treatment of diabetes mellitus: Tungsten (VI) compositions for the oral treatment of diabetes mellitus. Guinovart, Joan J.; Barbera, Albert; Rodriguez-gil, Joan E. (Quimica Farmaceutica Bayer S.A., Spain). U.S. US 5595763 A 21 Jan 1997, 8 pp. (English). (United States of America). CODEN: USXXAM. CLASS: ICM: A61K033-24. ICS: A61K031-28. NCL: 424617000. APPLICATION: US 1995-504020 19 Jul 1995. DOCUMENT TYPE: Patent CA Section: 63 (Pharmaceuticals) Section cross-reference(s): 1 The pharmaceutical compn. contains an effective amt. of a tungsten (VI) compd., preferably a tungstate or a isopolytungstate, and more preferably sodium tungstate. In the method of lowering blood sugar in a human suffering from type I or type II diabetes mellitus, an effective amt. of the compn. 13472-45-2 and 7790-60-5 which are cas registry numbers of substances are two of reagents here. is administered orally. Compared with the known vanadium compns., the invention has the advantage of providing a similar high sugar-lowering activity but with a much lower oral toxicity at EDs, both short- and long-term. Compared with insulin, the invention does not present the adverse effect of inducing hypoglycemia when administered in excess. .